OTCMKTS:CTYX Curative Biotechnology (CTYX) Stock Price, News & Analysis $0.0072 0.00 (-4.00%) As of 10/10/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Curative Biotechnology Stock (OTCMKTS:CTYX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Curative Biotechnology alerts:Sign Up Key Stats Today's Range$0.0069▼$0.007650-Day Range$0.0062▼$0.011952-Week Range$0.00▼$0.22Volume122,001 shsAverage Volume3.01 million shsMarket Capitalization$2.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL. Read More Receive CTYX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CTYX Stock News HeadlinesBuy Rating Justified by Tenaya Therapeutics’ Promising Gene Therapy AdvancementsOctober 11, 2024 | markets.businessinsider.comCue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingOctober 4, 2024 | markets.businessinsider.comBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff, as the world's biggest car firm prepares to launch a "mind blowing" new product. It has nothing to do with EVs, or self-driving cars. In fact, it's not a car at all...October 14 at 2:00 AM | Altimetry (Ad)CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer TreatmentAugust 29, 2024 | markets.businessinsider.comCurative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of DirectorsOctober 31, 2023 | tmcnet.comCurative Announces Spin-Off of Sensible Diagnostics with their Game-Changing 10-Minute Point-Of-Care PCR Testing PlatformMay 17, 2023 | finance.yahoo.comSOLVE FSHD Invests in Epic Bio to Advance Potentially Curative TherapyMay 16, 2023 | finance.yahoo.comCurative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop StudyJanuary 5, 2023 | wsj.comSee More Headlines CTYX Stock Analysis - Frequently Asked Questions How have CTYX shares performed this year? Curative Biotechnology's stock was trading at $0.0128 at the beginning of 2025. Since then, CTYX stock has decreased by 43.8% and is now trading at $0.0072. How do I buy shares of Curative Biotechnology? Shares of CTYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Curative Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Universal Display (OLED), Curative Biotechnology (CUBT), Telenav (TNAV), Semiconductor Manufacturing International (SIUIF), Cellular Biomedicine Group (CBMG), ANADIGICS (ANAD) and Intec Pharma (NTEC). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Miscellaneous Health & Allied Services Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CTYX CIKN/A Webwww.connectyx.com Phone(561) 418-7725FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares388,504,000Free FloatN/AMarket Cap$2.80 million OptionableNot Optionable Beta-33.99 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (OTCMKTS:CTYX) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
